Fred R. Ward

1.2k total citations
10 papers, 379 citations indexed

About

Fred R. Ward is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Fred R. Ward has authored 10 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Genetics. Recurrent topics in Fred R. Ward's work include RNA and protein synthesis mechanisms (9 papers), RNA modifications and cancer (4 papers) and Chemical Synthesis and Analysis (3 papers). Fred R. Ward is often cited by papers focused on RNA and protein synthesis mechanisms (9 papers), RNA modifications and cancer (4 papers) and Chemical Synthesis and Analysis (3 papers). Fred R. Ward collaborates with scholars based in United States, Sweden and France. Fred R. Ward's co-authors include J.H.D. Cate, Alanna Schepartz, Zoe L. Watson, Omer Ad, Raphaël Méheust, Jillian F. Banfield, Wenfei Li, Robert Dullea, Kim F. McClure and Spiros Liras and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Biochemistry.

In The Last Decade

Fred R. Ward

9 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fred R. Ward United States	7	340	69	32	24	19	10	379
Magdalena Schacherl Germany	8	198 0.6×	33 0.5×	14 0.4×	37 1.5×	12 0.6×	16	252
Nelli F. Khabibullina Russia	11	324 1.0×	43 0.6×	35 1.1×	26 1.1×	5 0.3×	13	389
Nikolay A. Aleksashin United States	8	343 1.0×	60 0.9×	21 0.7×	15 0.6×	6 0.3×	10	393
Daniel Eiler United States	11	398 1.2×	54 0.8×	30 0.9×	22 0.9×	4 0.2×	14	434
Zainab Ahdash United Kingdom	11	294 0.9×	50 0.7×	14 0.4×	29 1.2×	6 0.3×	14	394
Edward E. Pryor United States	9	251 0.7×	48 0.7×	19 0.6×	19 0.8×	8 0.4×	13	304
Arnaud Vanden Broeck United States	13	378 1.1×	48 0.7×	31 1.0×	61 2.5×	5 0.3×	16	457
Masahito Kawazoe Japan	9	507 1.5×	174 2.5×	65 2.0×	16 0.7×	4 0.2×	17	548
Rebecca Guymon United States	6	505 1.5×	88 1.3×	38 1.2×	26 1.1×	3 0.2×	7	528
Katharina Veith Germany	10	255 0.8×	57 0.8×	15 0.5×	13 0.5×	7 0.4×	13	334

Countries citing papers authored by Fred R. Ward

Since Specialization

Citations

This map shows the geographic impact of Fred R. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred R. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred R. Ward more than expected).

Fields of papers citing papers by Fred R. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred R. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred R. Ward. The network helps show where Fred R. Ward may publish in the future.

Co-authorship network of co-authors of Fred R. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Fred R. Ward. A scholar is included among the top collaborators of Fred R. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred R. Ward. Fred R. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Cavett, V., Fred R. Ward, Kim F. McClure, et al.. (2024). Activity-Based DNA-Encoded Library Screening for Selective Inhibitors of Eukaryotic Translation. ACS Central Science. 10(10). 1960–1968. 3 indexed citations

2.

Watson, Zoe L., et al.. (2023). Atomistic simulations of the Escherichia coli ribosome provide selection criteria for translationally active substrates. Nature Chemistry. 15(7). 913–921. 19 indexed citations

3.

Li, Wenfei, et al.. (2020). Selective inhibition of human translation termination by a drug-like compound. Nature Communications. 11(1). 4941–4941. 34 indexed citations

4.

Watson, Zoe L., Fred R. Ward, Raphaël Méheust, et al.. (2020). Structure of the bacterial ribosome at 2 Å resolution. eLife. 9. 162 indexed citations

5.

Travin, Dmitrii Y., Zoe L. Watson, Mikhail Metelev, et al.. (2019). Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition. Nature Communications. 10(1). 4563–4563. 46 indexed citations

6.

Li, Wenfei, Fred R. Ward, Kim F. McClure, et al.. (2019). Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule. Nature Structural & Molecular Biology. 26(6). 501–509. 54 indexed citations

7.

Ward, Fred R., Zoe L. Watson, Omer Ad, Alanna Schepartz, & J.H.D. Cate. (2019). Defects in the Assembly of Ribosomes Selected for β-Amino Acid Incorporation. Biochemistry. 58(45). 4494–4504. 15 indexed citations

8.

Tharp, Jeffery M., Omer Ad, Kazuaki Amikura, et al.. (2019). Initiation of Protein Synthesis with Non‐Canonical Amino Acids In Vivo. Angewandte Chemie. 132(8). 3146–3150. 5 indexed citations

9.

Tharp, Jeffery M., Omer Ad, Kazuaki Amikura, et al.. (2019). Initiation of Protein Synthesis with Non‐Canonical Amino Acids In Vivo. Angewandte Chemie International Edition. 59(8). 3122–3126. 41 indexed citations

10.

Glaeser, Robert M., Bong-Gyoon Han, Zoe L. Watson, Fred R. Ward, & J.H.D. Cate. (2018). Streptavidin Affinity Grids for cryo-EM. Biophysical Journal. 114(3). 163a–163a.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact